Ultragenyx Pharmaceutical financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

울트라제닉스 파머슈티컬NASDAQ:RARE · Nasdaq · Healthcare · sector #16

$14.46-0.28%

2026-10-06 close · prelim

Ultragenyx Pharmaceutical's published financial data is dated 2026-10-04. 2024 revenue was $560M. 2024 operating profit was −$536M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy